FI903154A0 - Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus. - Google Patents

Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus.

Info

Publication number
FI903154A0
FI903154A0 FI903154A FI903154A FI903154A0 FI 903154 A0 FI903154 A0 FI 903154A0 FI 903154 A FI903154 A FI 903154A FI 903154 A FI903154 A FI 903154A FI 903154 A0 FI903154 A0 FI 903154A0
Authority
FI
Finland
Prior art keywords
glykoproteiner
respiratory syncytial
syncytial virus
maenniskans
kimeriska
Prior art date
Application number
FI903154A
Other languages
English (en)
Other versions
FI102382B1 (fi
FI102382B (fi
Inventor
Michael Wathen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI903154A0 publication Critical patent/FI903154A0/fi
Application granted granted Critical
Publication of FI102382B1 publication Critical patent/FI102382B1/fi
Publication of FI102382B publication Critical patent/FI102382B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FI903154A 1987-12-23 1990-06-21 Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykopro teiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoprotei ineja varten FI102382B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13738787A 1987-12-23 1987-12-23
US13738787 1987-12-23
US8803784 1988-10-31
PCT/US1988/003784 WO1989005823A1 (en) 1987-12-23 1988-10-31 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus

Publications (3)

Publication Number Publication Date
FI903154A0 true FI903154A0 (fi) 1990-06-21
FI102382B1 FI102382B1 (fi) 1998-11-30
FI102382B FI102382B (fi) 1998-11-30

Family

ID=22477194

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903154A FI102382B (fi) 1987-12-23 1990-06-21 Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykopro teiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoprotei ineja varten

Country Status (14)

Country Link
US (2) US5194595A (fi)
EP (1) EP0396563B1 (fi)
JP (1) JP2716503B2 (fi)
KR (1) KR0137963B1 (fi)
AT (1) ATE85622T1 (fi)
AU (1) AU617739B2 (fi)
CA (1) CA1320163C (fi)
DE (1) DE3878468T2 (fi)
DK (1) DK173175B1 (fi)
FI (1) FI102382B (fi)
HK (1) HK166295A (fi)
MX (1) MX9203458A (fi)
NO (1) NO300254B1 (fi)
WO (1) WO1989005823A1 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914968D0 (en) * 1989-06-29 1989-08-23 Connaught Lab Production of virus and purification of viral envelope proteins for vaccine use
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US5824307A (en) 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
GB9200117D0 (en) 1992-01-06 1992-02-26 Connaught Lab Production of recombinant chimeric proteins for vaccine use
GB9207479D0 (en) * 1992-04-06 1992-05-20 Scotgen Ltd Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
TW275632B (fi) * 1992-04-21 1996-05-11 American Cyanamid Co
KR960700271A (ko) * 1993-01-08 1996-01-19 로렌스 티. 웰츠 인간 호흡계 합포체 바이러스 fg 당단백질의 정제 및 리폴딩 방법(process for the purification and refolding of human respiratory syncytial virus fg glycoprotein)
CA2163550A1 (en) * 1993-05-25 1994-12-08 Gerald E. Hancock Adjuvants for vaccines against respiratory syncytial virus
US7300918B2 (en) 1994-01-14 2007-11-27 Matthias Rath Method of producing vaccines from protein signal oligopeptides
EP1520859B9 (en) * 1994-01-14 2010-12-29 Rath, Matthias, Dr. med. Hydrophilic signal oligopeptides and methods of therapeutic use
FR2718452B1 (fr) * 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
US5789229A (en) * 1994-09-30 1998-08-04 Uab Research Foundation Stranded RNA virus particles
FR2726472B1 (fr) 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
DE4442114A1 (de) * 1994-11-25 1996-05-30 Buna Sow Leuna Olefinverb Gmbh Nitrit-, phosphat- und aminfreies Kühl- und Wärmeübertragungsmittel
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US6015664A (en) * 1995-11-03 2000-01-18 Mcw Research Foundation Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B
AU6908598A (en) * 1996-10-29 1998-05-22 Smithkline Beecham Biologicals (Sa) Purification of respiratory syncytial virus antigens
AU756620B2 (en) 1997-07-14 2003-01-16 University Of Liege Mutations in the myostation gene cause double-muscling in mammals
US6103466A (en) * 1997-07-14 2000-08-15 University Of Liege Double-muscling in mammals
US20070067859A1 (en) * 1997-07-14 2007-03-22 Michel Georges Double-muscling in mammals
US6699478B1 (en) * 1997-09-19 2004-03-02 Wyeth Holdings Corporation Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus
GB9909077D0 (en) 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
US6656467B2 (en) * 2000-01-27 2003-12-02 Medimmune, Inc. Ultra high affinity neutralizing antibodies
DK1259547T3 (da) 2000-03-01 2012-10-15 Medimmune Inc Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
ATE452625T1 (de) * 2004-05-24 2010-01-15 Polymun Scient Immunbio Forsch Superbeladene liposome für die arzneimittelabgabe
AU2005302453A1 (en) * 2004-10-29 2006-05-11 Medimmune, Llc Methods of preventing and treating RSV infections and related conditions
EP1997830A1 (en) * 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
EP3508505A1 (en) 2007-12-24 2019-07-10 ID Biomedical Corporation of Quebec Recombinant rsv antigens
BRPI0915960A2 (pt) * 2008-07-18 2019-09-24 Id Biomedical Corp antígenos de polipeptídeos do vírus sincicial respiratório qimérico
PL2445526T3 (pl) 2009-06-24 2017-08-31 Glaxosmithkline Biologicals S.A. Rekombinowane antygeny rsv
WO2011008974A2 (en) 2009-07-15 2011-01-20 Novartis Ag Rsv f protein compositions and methods for making same
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
EA201891945A3 (ru) 2012-08-01 2019-05-31 Бавариан Нордик А/С Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
JPH01501357A (ja) * 1986-01-14 1989-05-18 ユニバ−シテイ・オブ・ノ−ス・カロライナ ヒト呼吸器系ウイルス用ワクチン
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
SG106639A1 (en) * 2000-10-10 2004-10-29 Gen Electric Apparatus and method for introducing small amounts of refractory elements into a vapor deposition coating

Also Published As

Publication number Publication date
FI102382B1 (fi) 1998-11-30
CA1320163C (en) 1993-07-13
US5194595A (en) 1993-03-16
KR900700508A (ko) 1990-08-13
NO902802L (no) 1990-06-22
MX9203458A (es) 1992-09-01
HK166295A (en) 1995-11-03
NO300254B1 (no) 1997-05-05
US5288630A (en) 1994-02-22
ATE85622T1 (de) 1993-02-15
JP2716503B2 (ja) 1998-02-18
FI102382B (fi) 1998-11-30
EP0396563B1 (en) 1993-02-10
DK173175B1 (da) 2000-03-06
WO1989005823A1 (en) 1989-06-29
EP0396563A1 (en) 1990-11-14
JPH03501723A (ja) 1991-04-18
KR0137963B1 (ko) 1998-04-30
DK153290A (da) 1990-08-16
DE3878468D1 (de) 1993-03-25
AU2785089A (en) 1989-07-19
DK153290D0 (da) 1990-06-22
AU617739B2 (en) 1991-12-05
DE3878468T2 (de) 1993-06-09
NO902802D0 (no) 1990-06-22

Similar Documents

Publication Publication Date Title
FI903154A0 (fi) Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus.
NO904538L (no) Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3.
ATE163682T1 (de) Respiratorisches syncytiales virus, impstoffe
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
DE60041280D1 (de) Chimäre mensch-rinder respiratory syncytial virus vakzinen
EA200100302A1 (ru) Способы и композиции для протективной и терапевтической генетической иммунизации
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
ATE234917T1 (de) Avirulente salmonella mikroben mit einer mutation in dem cdt gen und ihre verwendung
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
MY101874A (en) Vaccine
DE3582422D1 (de) Biologische zubereitungen.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY

FG Patent granted

Owner name: PHARMACIA & UPJOHN COMPANY

MA Patent expired